A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma

Chimeric antigen receptor (CAR) T-cell therapy is a new standard of care for patients with diffuse large B-cell lymphoma (DLBCL); however, studies including healthcare resource utilization (HRU) during routine care are lacking. Accordingly, a population-based study was conducted using linked adminis...

Description complète

Détails bibliographiques

Auteurs principaux:	Lee Mozessohn, Pierre J. A. Villeneuve, Nibene H. Somé, Rebecca E. Mercer, Lisa Masucci, Tom Kouroukis, Christopher Bredeson, Suriya Aktar, Qi Guan, Anca Prica, Christine I. Chen, Danielle Rodin, Matthew C. Cheung, Munaza Chaudhry, Scott Gavura, Cassandra McKay, William W. L. Wong, Kelvin K. W. Chan
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2026-06-01
Collection:	Current Oncology
Sujets:	chimeric antigen receptor T-cell therapy diffuse large B-cell lymphoma real-world evidence
Accès en ligne:	https://www.mdpi.com/1718-7729/33/6/366
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!